BioSpace News Archive

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the Board of Directors has declared a quarterly dividend of $0.65 per share of the company’s common stock for the second quarter of 2021.

ATI Physical Therapy, one of the nation’s largest providers of physical therapy services, announced the appointment of Ryan Wilson to Chief Commercial Officer.

Soterix Medical Inc. (SMI), the global leader in non-invasive stimulation and synergistic brain imaging technologies, announces a new clinical trial of home-based auricular Vagus Nerve Stimulation (taVNS) for individuals who experience post-COVID neuropsychiatric symptoms, like fatigue, headache, or anxiety

YPrime, LLC., a global leader in cloud-based eClinical solutions, announced today the launch of their fifth-generation electronic clinical outcome assessment (eCOA) platform

Novelion Therapeutics Inc. (“ Novelion ” or the “ Company ”) by Alvarez & Marsal Canada Inc., Novelion’s court appointed liquidator (the “ Liquidator ”) today announces that the timing of the previously announced interim distribution to its registered shareholders (the “ Interim Distribution ”) has been delayed.

Amgen (NASDAQ:AMGN) will host a webcast call for the investment community in conjunction with the 2020 World Conference on Lung Cancer (WCLC) on Friday, Jan. 29 , at 8:00 p.m. ET .

Psychemedics Corporation announced that Andrew Limbek has joined the Company as Vice President, Controller.

Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (the “Company”), a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests, today announced that it has received a notification letter from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it has been granted an additional 180 calendar day period to regain compliance with the minimum bid price requirement

For the third year in a row, CooperCompanies has been designated as Great Place to Work-Certified™ organization based on a detailed evaluation of workplace culture and the employee experience.

Invitae Corporation announced the closing of its underwritten public offering of 8,932,038 shares of its common stock, including 1,165,048 shares sold pursuant to the exercise in full of the underwriters’ option to purchase additional shares, at the public offering price of $51.50 per share.